Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)

NCT06280482 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Smooth Muscle Dysfunction Syndrome (SMDS)

Interventions

DRUG: Nicotinamide riboside (NR)

Sponsor

The University of Texas Health Science Center, Houston